Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Synaptogenix Announces Collaboration With LSU Health New Orleans For Pre-Clinical Testing Of PUFA Analogs For Spinal Cord Injury

Author: Benzinga Newsdesk | July 18, 2024 09:05am

New Patent Issued Covering Treatment Of Neurodegenerative Diseases; Studies To Compare Analogs With Bryostatin In SCI

Posted In: SNPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist